New TB technology may be ready for clinics
Conducted in part by the University of Cape Town (UCT), the study looked at whether it was possible for nurses – instead of laboratory technicians – to administer the test in clinics in four countries, South Africa, Zimbabwe, Zambia and Tanzania.
Introduced in South Africa in 2011, the GeneXpert can diagnose TB as well as some forms of drug-resistant TB in just hours. Conventional TB testing, which relied on microscopes and chest x-rays, can take weeks. These methods also miss up to 60 percent of TB cases.
However, the GeneXpert is currently only largely used in South African laboratories, meaning clinics must send samples to these labs for testing and wait several days for results to come back.
“We asked a simple question, if we put this technology in the clinic and the test is performed by a minimally trained health care worker will that impact on patient drop out and what are the potential benefits of that strategy?” says study co-author. Keertan Dheda from UCT’s Department of Medicine.
Published in the 28 October online edition of the Lancet, Dheda’s study found that nurses could accurately run the GeneXpert machines with a single day’s training.
The research also found that placing GeneXperts in clinics doubled the same day diagnostic rate and also increased the number of patients starting same day treatment by 50 percent.
“What this translates into is halving patient drop out so a lot more patients returned or were put on treatment compared to those who were tested using traditional smear microscopy,” he explains.
Only half of all patients diagnosed with multidrug-resistant (MDR-TB) in South Africa receive treatment.
Expanding access to the GeneXpert, which can also diagnose MDR-TB, will help the country combat rising rates of extensively drug-resistant TB (XDR-TB), Dheda says.
“Unless we rapidly diagnose cases of MDR-TB and rapidly act to treat these patients then this problem of XDR-TB and incurable TB is going to get bigger and bigger,” warns Dheda, who suggests placing GeneXperts in clinics in drug-resistant TB hotspots around the country.
Each year, South Africa reports more cases of XDR-TB than any other country in the world. Only 16 percent of TB cases are currently tested for MDR-TB.
MDR-TB is resistant to both commonly used anti-TB drugs. XDR-TB is resistant to these drugs as well as at least half of the mostly commonly used second-line drugs. – Health-e News Service.
Author
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
New TB technology may be ready for clinics
by laurawatermeyer, Health-e News
October 31, 2013